Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Rectal Indomethacin Plus Aggressive Hydration as Prophylaxis to Prevent Post-ERCP Pancreatitis at a Secondary-Care Teaching Hospital: A Randomized Controlled Trial.

NCT07599605 is registered in ClinicalTrials.gov with Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo as lead sponsor.

NCT NCT07599605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07599605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Rectal Indomethacin Plus Aggressive Hydration as Prophylaxis to Prevent Post-ERCP Pancreatitis at a Secondary-Care Teaching Hospital: A Randomized Controlled Trial.
Lead sponsor
Hospital General de Chihuahua - Dr. Salvador Zubirán Anchondo
Phase
Phase 3
Overall status
Completed
Start date
March 4, 2024
Completion date
January 17, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ercp, pancreatitis